PharmExec Blog
Follow Us
RSS
Bookstore
Tag Archives: Detailing
US v. Caronia: What Constitutes 'Truthful' Speech?
If a drug’s label is not the final word on what is true – or untrue – about a product, then who decides what can and cannot be said during a sales detail?
Posted in Advertising, FDA, Legal, Marketing, Regulatory, Safety, Sales, Strategy, compliance Also tagged Alfred Caronia, Appeals Court, DoJ, FDA, Federal Trade Commission, FTC, Jazz Pharmaceuticals, Marketing, off-label, Office of Prescription Drug Promotion, Orphan Medical, OTC, Professional Marketing, Promotion, Regulatory, sales rep, Sorrell v. IMS Health, US v. Caronia 1 Comment
Sales Rep vs. eDetail: Consider the Practice Area
Forget illegal immigrants, it is machines that are stealing American jobs. For some medical practice areas, however, digital details haven’t sufficiently stepped in where their human sales rep predecessors have stepped (or have been pushed) out, according to a survey of U.S. physicians.
Posted in Advertising, E-Media, Marketing, Sales, Strategy Also tagged e-detailing, sales force 2 Comments
New FDA Campaign Targets Detailing, Trade Shows
In addition to sending out more warning letters and stepping up enforcement activity, the Food and Drug Administration wants health professionals to do more to police drug marketing and advertising. The agency’s “Bad Ad” program urges doctors and other health professionals to report any false or misleading ads or inappropriate marketing pitches. Depending on one’s [...]
Posted in FDA, News, Regulatory Also tagged Advertising, DDMAC, FDA, Margaret Hamburg, Marketing, Professional Marketing Leave a comment
Pharma's Promotional Spend: What's the Right Target?